- Home/In The News/Blog/2014/May
16
May2014
category:
503b CompoundingWeekly FDA Enforcement Report For Drugs And Biologics 5/14/14
The Food and Drug Administration (FDA) has released its Drug and Biological product Enforcement Report for May 14, 2014. The agency publicizes recalls in its weekly report as press releases are not issued for all recalls. Manufacturers issue recalls voluntarily or the FDA initiates the action. View the recalls by Biologics or Drugs, and by Classification. Classification I Recall […]
read more16
May2014
category:
503b CompoundingINDIA – Wockhardt recalls over 1 lakh bottles of hypertension drug in US
Drugmaker Wockhardt is recalling 1,09,744 bottles of a high blood pressure drug in the United States after it failed a dissolution test, the US Food and Drug Administration has said. The recall of metoprolol succinate began in April and was posted on the FDA website late Wednesday. Metoprolol succinate extended release is a cheaper generic form of […]
read more15
May2014
category:
503b CompoundingGeneric Drug Economics at Root of Many Drug Shortages
The generic drug market’s economics have a particular impact on drug shortages, including shortages of critical drugs that may only be available in generic form, a report from the US Government Accountability Office (GAO) states. Most of the shortages within the past 2 years, including half of critical shortages, involve injectable generic drugs, GAO reports […]
read more